ArticleVaccines2023

Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study.

Merav Heshin-Bekenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.